Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Lisinopril Tablets in Primary Hypertension
CTR20213095Phase 3Completed
- Sponsor
- Sichuan Shangrui Biopharmaceutical
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lisinopril in essential hypertension, sponsored by Sichuan Shangrui Biopharmaceutical. Started Dec 2021; status: completed.
02
Drugs
lisinopril
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20213095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20213095.